Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good Morning All - Hope all is well.
Slide-Show. 20 Stocks With the Potential to Pop:
http://www.cnbc.com/id/49120939
Check out SMAA. Today's Goldman Research Report is out on SMAA. Here's an excerpt from the report. SMAA closed at .12 yesterday and the report has a target of 1.50. See below:
With millions in annual revenue essentially locked up
for 2013 due to the Cars.net deal, SMA could generate
nearly $20M in revenue in 2013.
The pending IPO of industry player AutoTrader should
soon raise SMAA’s valuation.
With additional M&A and milestones ahead, we
believe SMAA is primed to reach our $1.50 price
target. As success occurs, SMAA could even be an M&A
target, due to the depth and efficiency of its technology
and its ability to be replicated in other industries. We rate
SMAA Speculative Buy.
KFT. Kraft Foods Group joining S&P 500
Kraft Foods Group joining S&P 500, Alpha Natural Resources joining S&P MidCap 400
http://finance.yahoo.com/news/kraft-foods-group-joining-p-111042508.html
[img]stockcharts.com/c-sc/sc?
Golden Cross 'Hot List' Wednesday. with chart links.
[Stockholla]
http://investorshub.advfn.com/The-Golden-Cross-&-Bags-of-10!-24957/
MJNA:http://stockcharts.com/h-sc/ui?s=MJNA&p=D&b=5&g=0&id=p16720501230
XRMB:http://stockcharts.com/h-sc/ui?s=XRMB&p=D&yr=0&mn=5&dy=0&id=p96474638583 (just keep on going up!! Amazing)
ASTX:http://stockcharts.com/h-sc/ui?s=ASTX&p=D&b=5&g=0&id=p44375063002
LGBS:http://stockcharts.com/h-sc/ui?s=LGBS&p=D&b=5&g=0&id=p04809947471
CMGO: http://stockcharts.com/h-sc/ui?s=CMGO&p=D&b=5&g=0&id=p96594207646
DPZ: http://stockcharts.com/h-sc/ui?s=DPZ&p=D&b=5&g=0&id=p95378999407
FITX:http://stockcharts.com/h-sc/ui?s=FITX&p=D&b=5&g=0&id=p70230767714
ROSG: http://stockcharts.com/h-sc/ui?s=ROSG&p=D&b=5&g=0&id=p65732623099
APDN:http://stockcharts.com/h-sc/ui?s=APDN&p=D&yr=0&mn=6&dy=0&id=p91253406118
Post Unavailable
Good Afternoon Speakeasy ~ spending the day on the island.
Just went apple and pumpkin picking. Now stopping at the vineyards.
Happy Trading
Trade with caution and be prepared to go liquid quickly.
CRY -Forgot to mention the company even pays a dividend now since my original buy in April of this year.
The initial quarterly cash dividend of $0.025 per share will be paid on September 21, 2012 to all common stockholders of record as of September 14, 2012. The ex-dividend date for the quarterly dividend is September 12, 2012.
http://www.siliconinvestor.com/readmsg.aspx?msgid=28107667&srchtxt=cry
CRY-Cryolife 52 week high yesterday and today!
Capital Link Shipping Weekly Markets Report. PDF.(download)
http://files.irwebpage.com/_download_file.php?f=newsletters/shipping/2012/shipping_newsletter_week39.pdf&p=shipping&e=poemstone@excite.com
Dividend increased every/year. ADP. PPG. GPC.
ADP. Each year for 37 straight years. Yield this year 2.7%
iHub. http://ih.advfn.com/p.php?pid=squote&symbol=ADP
PPG. Each year for 41 straight years. Yield this year 2.0%
iHub. http://ih.advfn.com/p.php?pid=squote&symbol=PPG
GPC. Each year for 56 straight years. Yield this year 3.2%
NAPA auto parts stores.
iHub. http://ih.advfn.com/p.php?pid=squote&symbol=GPC
Reverse head & Shoulders.
Good Morning Speakeasy ~ the distractions continue indefinitely
Trade with caution.
Presidential election and war with Iran could make the market a horrible place if your not on top of it.
MSG. Madison Square Garden. info-sheet.
Website. http://www.themadisonsquaregardencompany.com/
MSG Club. http://www.thegarden.com/tickets.html
iHub. No Mod. 16 posts. 3 follows.
8/24/12 Madison Square Garden 4th-Quarter Profit Soars on Sports Revenue
http://ih.advfn.com/p.php?pid=nmona&article=53936359
8/24/12 10-K
Number of shares of common stock outstanding as of July 31, 2012 :
Class A Common Stock — 62,017,285
Class B Common Stock — 13,588,555
http://ih.advfn.com/p.php?pid=nmona&article=53943731
7/12/12 LivingSocial & MadisonSquareGarden (MSG) to provide premium offers
http://www.otcmarkets.com/stock/MSG/news
7/13/12 Zacks #2 buy Enters Oversold Territory
http://ih.advfn.com/p.php?pid=nmona&article=53459223
6/26/12 Madison Square Garden Company Acquires Famed Forum Arena
http://ih.advfn.com/p.php?pid=nmona&article=52893051
5/7/12 Fox Business News
MSG CEO on the Arena’s $980M Makeover [video]
http://video.foxbusiness.com/v/1678909371001/msg-ceo-on-the-arenas-980m-makeover/?playlist_id=87247
5/4/12 10-Q/3
Third quarter revenue of $400.5 million, a 21% increase compared to prior year period
Third quarter AOCF of $80.2 million, a 46% increase compared to prior year period
Third quarter operating income of $53.3 million, up 75% versus prior year period
http://ih.advfn.com/p.php?pid=nmona&article=52285799
$NBRI..Put some GOLD,PM's and REE's into your LT portfolio to add tremendous value..No other penny miner has the assets that NBRI does!>>>>>http://www.northbayresources.com/
Understood and will be watching
Always appreciated friend :)
Good morning speakeasy - im still lurking, being cautious with my trades due to my crazy schedule, dont want to get stuck.
$CMGO
$CBIS
$SEEK
$RCHN
DPZ. (buy-dip)? Jim Cramer video CEO interview. link:
no iHub mod.
http://video.cnbc.com/gallery/?video=3000117207
I've sold out my CBM position. Great ride since initial post.
RE:CBM Cambrex Corporation. 6.87
Continued to add to CRY-Cryolife
CBIS. NBC News Reports that Cannabidiol (CBD) "Turns Off" the Cancer Gene Involved in Metastasis Findings by Scientists at California Pacific Medical Center gives Scientific Support for Cannabis Science Initiatives
http://finance.yahoo.com/news/nbc-news-reports-cannabidiol-cbd-174500212.html
Hi richardred. I'm not in SVNT.
oil and natural gas / commodities. always being manipulated.
POEM- After taking a loss last fall. I still own some of this one.
They sure need some new indications. Takeover appeal IMO now reduced. However if positive trend continues in KRYSTEXXA® sales. Somebody might come back to the table at a much reduced price.
$SEEK - TheDirectory.com Launches Version 3.0 of Its Local Business Directory
Link: http://ih.advfn.com/p.php?pid=nmona&article=54243814&symbol=SEEK
TheDirectory.com, Inc. (PINKSHEETS: SEEK), an emerging leader in the Vertical and Local search space, today announced that it has launched the third version of www.TheDirectory.com, its Local business search engine.
TheDirectory.com Founder and CEO Scott Gallagher commented, "We're very excited to launch the new and improved version 3.0 of www.TheDirectory.com. This new version of the platform is a dramatic improvement from version 2.0. It expands the core functionality for our clients and allows us to manage our entire network of Local directories from a single location. Local businesses in both the U.S. and Canada can now create free Local business listings within www.TheDirectory.com." Gallagher continued, "Over the coming weeks we'll be rolling out a new website builder and mobile website builder. These new products coupled with our Local directory will provide businesses with the three most important features they care about: a website, a mobile website and online exposure for their business."
TheDirectory.com, Inc. will be filing its Q3 financials on OTC Markets on October 11, 2012 at which time the Company will complete the process of removing the stop sign and up-list to OTC Pink Current.
About TheDirectory.com, Inc.
TheDirectory.com is a diversified Local and Vertical Internet search company that owns and operates a network of Locally targeted, category specific, search destinations anchored by its Local business search engine www.TheDirectory.com, other sites in the network include: www.LocalAttorney.net, www.Chiropractor.net, www.Therapists.net, www.Dietitians.net, www.DentistAppointments.com, and many others. For more information see the Company's financial statements and related filings on www.OTCMarkets.com.
Certain statements contained herein are "forward-looking" statements (as defined -- Private Securities Litigation Reform Act of 1995). TheDirectory.com, Inc. cautions that the statements made in this press release constitute forward-looking statements and no guarantees of future performance and actual results or developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at time the statements are made.
$SEEK
SVNT. Savient Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting
http://finance.yahoo.com/news/savient-announces-multiple-abstracts-related-113000941.html
DYAX. Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html
ANSS. ANSYS Listed On Software 500 Index For Sixth Consecutive Year
Engineering Simulation Software Provider Recognized as One of the World's Largest Software Companies
http://finance.yahoo.com/news/ansys-listed-software-500-index-112500397.html
UTHR. United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
http://finance.yahoo.com/news/united-therapeutics-announces-collaboration-ascendis-100000890.html
Pall Corp. To Open Latest Life Sciences Center of Excellence in New England
http://finance.yahoo.com/news/pall-corp-open-latest-life-210100658.html
BIIB. The New England Journal of Medicine Publishes Pivotal Data Demonstrating Efficacy and Safety of Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Results of Phase 3 DEFINE and CONFIRM Studies Support Dimethyl Fumarate’s Potential as a Strong Option for MS Treatment
http://finance.yahoo.com/news/england-journal-medicine-publishes-pivotal-210000550.html
CVS. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $6 Billion of Common Stock
Company Also Announces Quarterly Dividend
http://finance.yahoo.com/news/cvs-caremark-corporation-announces-share-194700515.html
CELG. Celgene Corporation Announces Pomalidomide Will Be Reviewed at FDA Advisory Committee
ODAC will discuss pomalidomide NDA for the treatment of patients with relapsed and refractory multiple myeloma
http://finance.yahoo.com/news/celgene-corporation-announces-pomalidomide-reviewed-134100851.html
happy to have you on board - wish i wasnt so distracted lately
underworld rumblings are speaking of big dip in october - war and oil related - keep your ears to the ground for it
hi my friend, thank you lots.
Good Morning All- Been super busy. Please welcome Mick on board :)
Pleasure to have you one.
GTXI. GTx Announces Presentation on the Ability of Capesaris® to Reduce Free Testosterone and Suppress PSA in Men With Castration Resistant Prostate Cancer
http://finance.yahoo.com/news/gtx-announces-presentation-ability-capesaris-110000978.html
SPPI. Spectrum Pharmaceuticals Initiates Phase 3 Study of ZEVALIN® in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL); Most Common Form of Aggressive Non-Hodgkin’s Lymphoma
• There is a substantial need for better treatments for DLBCL, which has low survival rates at five years; there are an estimated 20,000 new cases of DLBCL in the U.S. each year
• The ZEST study follows multiple Phase 2 clinical trials supporting advancement of ZEVALIN into a registrational-quality study in aggressive lymphoma; results from the largest of the studies, presented at the 2012 European Hematology Association annual meeting, showed an 84% 5-year overall survival (OS) rate and 75% 5-year progression-free survival (PFS) in older patients with stage II-IV DLBCL who received ZEVALIN following R-CHOP
• The ZEST (Zevalin Evaluation as Sequential Therapy) study will compare the ZEVALIN therapeutic regimen to observation in patients with newly diagnosed stage II, III, or IV DLBCL who are 60 years of age and older and who are in complete remission after first-line R-CHOP or R-CHOP like chemotherapy for their disease
• Primary endpoint is overall survival; secondary endpoints include 2-year OS rate and PFS
• Additional ZEVALIN clinical studies in aggressive lymphoma include the SPINOZA (Study with Preparatory INduction Of Zevalin in Aggressive lymphoma) trial, which to date has randomized 39 patients receiving autologous stem cell transplantation (ASCT) for relapsed DLBCL
http://finance.yahoo.com/news/spectrum-pharmaceuticals-initiates-phase-3-110000814.html
OMER. Omeros Awarded NIMH Grant for Development of Orphan GPCR Antibodies
-- Omeros' Proprietary Antibody Platform Enables Rapid Discovery --
http://finance.yahoo.com/news/omeros-awarded-nimh-grant-development-110000319.html
hmmm. Bloomberg-video. McNamee: Apple, Making Big Mistakes? link
http://www.bloomberg.com/video/popout/FwqDoEHTTBu7Mu~Zyky~hg/00:00/
i am updating, anything to carry for ya?
GILD. Gilead Sciences to Present at the UBS Global Life Sciences Conference on Wednesday, September 19
http://finance.yahoo.com/news/gilead-sciences-present-ubs-global-203000239.html
APPY. after/hours. AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
http://finance.yahoo.com/news/aspenbio-announces-dismissal-class-action-202000869.html
QDEL. Quidel Receives CE Mark for Its Sofia(R) RSV Fluorescent Immunoassay (FIA) Test
http://finance.yahoo.com/news/quidel-receives-ce-mark-sofia-193000808.html
MACK. Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
Research Presented at ESMO 2012 Congress Address Safety and Preliminary Efficacy of Treatments Discovered and Developed through Network Biology
http://finance.yahoo.com/news/merrimack-pharmaceuticals-present-preliminary-clinical-155100637.html
$NBRI>>>>>..Here is the link for the Legal counsel in China that is advertising for investors for the Ruby Gold Project.The investment will be paid off in 42 months.
http://www.yimin-visa.com/en/news_view_1688_465.html
$FORC - Projects : Hayter Well (Alberta, Canada)
http://www.forceenergycorp.com/hayterwell.php
Force Energy Corp. maintains a 50% working interest in County Line Energy Corp. interest in the Hayter Well (10D Hayter 10-8-40-1 W4M) located in Alberta, Canada. The well was spudded in January 2007 and drilled to a total depth. The well logs revealed a gas zone of 4 to 5 meters of thickness in a shallow zone and a heavy oil pay zone of 2 meters of thickness in the target Dina Sand zone. Although the results in the Dina sand were lower than expected and a decision was made to case the well in 2007, should prices rise in the future, the Hayter could produce an economic well.
County Line Energy completed a $650,000 3D seismic program covering nine sections of land in pursuit of a potential multi well heavy oil drilling opportunity. The geological model was based on interpretation from a previous well, which produced 16,000 barrels of heavy oil. The seismic program was designed to determine whether the structure found in this well existed to a larger extent on the subject property. The 3D seismic revealed an extremely large anomaly with similar characteristics. The nature of this large anomaly suggested that a multi well drilling opportunity might exist. Although this well will likely be completed as a producing well the results of the drilling have negated the ultimate potential of the Hayter property.
Followers
|
64
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5074
|
Created
|
12/30/11
|
Type
|
Free
|
Moderator qwertytrader | |||
Assistants mick ontopofit fast.money |
Posts Today
|
0
|
Posts (Total)
|
5074
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |